These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12142636)

  • 1. Free and glucuronidated olanzapine serum concentrations in psychiatric patients: influence of carbamazepine comedication.
    Linnet K; Olesen OV
    Ther Drug Monit; 2002 Aug; 24(4):512-7. PubMed ID: 12142636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine serum concentrations in psychiatric patients given standard doses: the influence of comedication.
    Olesen OV; Linnet K
    Ther Drug Monit; 1999 Feb; 21(1):87-90. PubMed ID: 10051059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting.
    Skogh E; Reis M; Dahl ML; Lundmark J; Bengtsson F
    Ther Drug Monit; 2002 Aug; 24(4):518-26. PubMed ID: 12142637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine serum concentrations in psychiatric patients: the influence of comedication.
    Hasselstrøm J; Linnet K
    Ther Drug Monit; 2004 Oct; 26(5):486-91. PubMed ID: 15385830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring of serum olanzapine during antipsychotic treatment].
    Linnet K; Olesen OV
    Ugeskr Laeger; 2000 Sep; 162(36):4802-5. PubMed ID: 10994377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine serum concentrations lowered by concomitant treatment with carbamazepine.
    Licht RW; Olesen OV; Friis P; Laustsen T
    J Clin Psychopharmacol; 2000 Feb; 20(1):110-2. PubMed ID: 10653223
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.
    Carrillo JA; Herráiz AG; Ramos SI; Gervasini G; Vizcaíno S; Benítez J
    J Clin Psychopharmacol; 2003 Apr; 23(2):119-27. PubMed ID: 12640212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism.
    Lucas RA; Gilfillan DJ; Bergstrom RF
    Eur J Clin Pharmacol; 1998 Oct; 54(8):639-43. PubMed ID: 9860152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of olanzapine and its N-desmethyl and 2-hydroxymethyl metabolites in child and adolescent psychiatric disorders: effects of dose, diagnosis, age, sex, smoking, and comedication.
    Theisen FM; Haberhausen M; Schulz E; Fleischhaker C; Clement HW; Heinzel-Gutenbrunner M; Remschmidt H
    Ther Drug Monit; 2006 Dec; 28(6):750-9. PubMed ID: 17164690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication.
    Gex-Fabry M; Balant-Gorgia AE; Balant LP
    Ther Drug Monit; 2003 Feb; 25(1):46-53. PubMed ID: 12548144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.
    Markowitz JS; Devane CL; Liston HL; Boulton DW; Risch SC
    Clin Pharmacol Ther; 2002 Jan; 71(1):30-8. PubMed ID: 11823755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine drug interactions in a TDM material.
    Böttiger Y; Svensson JO; Ståhle L
    Ther Drug Monit; 1999 Apr; 21(2):171-4. PubMed ID: 10217336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants.
    Gardiner SJ; Kristensen JH; Begg EJ; Hackett LP; Wilson DA; Ilett KF; Kohan R; Rampono J
    Am J Psychiatry; 2003 Aug; 160(8):1428-31. PubMed ID: 12900304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 2000 Oct; 61(10):742-9. PubMed ID: 11078035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.
    Spina E; D'Arrigo C; Santoro V; Muscatello MR; Pandolfo G; Zoccali R; Diaz FJ; de Leon J
    Ther Drug Monit; 2009 Dec; 31(6):758-63. PubMed ID: 19865002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment.
    Schoretsanitis G; Haen E; Gründer G; Stegmann B; Schruers KR; Hiemke C; Lammertz SE; Paulzen M
    J Clin Psychopharmacol; 2016 Dec; 36(6):554-561. PubMed ID: 27811552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection.
    Gervasini G; Vizcaíno S; Herráiz AG; Benítez J; Carrillo JA
    Clin Chem; 2003 Dec; 49(12):2088-91. PubMed ID: 14633885
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.
    Spina E; Avenoso A; Facciolà G; Salemi M; Scordo MG; Giacobello T; Madia AG; Perucca E
    Ther Drug Monit; 2000 Aug; 22(4):481-5. PubMed ID: 10942191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine excretion in human breast milk: estimation of infant exposure.
    Croke S; Buist A; Hackett LP; Ilett KF; Norman TR; Burrows GD
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):243-7. PubMed ID: 12366877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.